146 related articles for article (PubMed ID: 7007031)
1. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
[No Abstract] [Full Text] [Related]
2. On the pathogenetic role of prostaglandins in Bartter's syndrome.
Nielsen I; Hesse B; Christensen P
Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
[TBL] [Abstract][Full Text] [Related]
3. Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
Tamura Y; Matsuda Y; Yamada K; Takagi T; Nishikawa T; Watanabe M; Mikami K; Moriya H; Kumagai A
Adv Exp Med Biol; 1979; 120B():515-24. PubMed ID: 517245
[No Abstract] [Full Text] [Related]
4. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
[TBL] [Abstract][Full Text] [Related]
5. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
[TBL] [Abstract][Full Text] [Related]
6. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
Shimoyama R
J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
[TBL] [Abstract][Full Text] [Related]
7. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
Rudin A; Aurell M; Hansson L; Westberg G
Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome.
Hsieh BS; Chen WY; Yen TS; Lai MS
Taiwan Yi Xue Hui Za Zhi; 1978 Nov; 77(11):831-8. PubMed ID: 284093
[No Abstract] [Full Text] [Related]
9. Bartter's syndrome results from an imbalance of vasoactive hormones.
McGiff JC
Ann Intern Med; 1977 Sep; 87(3):369-72. PubMed ID: 900681
[TBL] [Abstract][Full Text] [Related]
10. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
[TBL] [Abstract][Full Text] [Related]
11. Responses to antiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome.
Sasaki H; Okumura M; Asano T; Arakawa K; Kawasaki T
Br Med J; 1977 Oct; 2(6093):995-6. PubMed ID: 922403
[No Abstract] [Full Text] [Related]
12. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
[TBL] [Abstract][Full Text] [Related]
13. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
Vierhapper H; Waldhäusl W
Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and qualitative estimation of urinary kallikrein in a patient with Bartter's syndrome.
Yamada K; Watanabe M; Nishikawa T; Mikami K; Shirai K; Tamura Y; Yamamoto M; Kumagai A; Matsuda Y; Moriya H
Endocrinol Jpn; 1978 Dec; 25(6):583-9. PubMed ID: 751804
[TBL] [Abstract][Full Text] [Related]
15. The role of prostaglandins in Bartter's syndrome.
Winterborn MH; Hewitt GJ; Mitchell MD
Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
[TBL] [Abstract][Full Text] [Related]
16. [Bartter's syndrome--a case study with special reference to the role of renal prostaglandins and the renin-angiotensin-aldosterone system].
Sato M; Abe K; Hoshima M; Chiba S; Ritsu K
Horumon To Rinsho; 1979 Jan; 27(1):51-7. PubMed ID: 428121
[No Abstract] [Full Text] [Related]
17. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
[TBL] [Abstract][Full Text] [Related]
18. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
19. Urinary kallikrein excretion in Bartter's syndrome.
Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
[TBL] [Abstract][Full Text] [Related]
20. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
Hornych A
Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
